Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
Louise Cunningham, Ian Kimber, David A. Basketter, John Mcfadden
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineIntensive care medicinePandemicVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Impact on ReproductionInflammasome and immune disordersCOVID-19 Clinical Research Studies